Your browser doesn't support javascript.
loading
IMPLICATIONS OF COMPLETE POSTERIOR VITREOUS DETACHMENT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION.
Zheng, Yuxi; Woodward, Richmond; Feng, Henry L; Lee, Terry; Zhang, Xinxin; Pant, Praruj; Thomas, Akshay S; Fekrat, Sharon.
Afiliación
  • Zheng Y; Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.
  • Woodward R; Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.
  • Feng HL; Illinois Retina Associates, Rush University Medical Center, Chicago, Illinois ; and.
  • Lee T; Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.
  • Zhang X; Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.
  • Pant P; Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.
  • Thomas AS; Tennessee Retina, Nashville, Tennessee.
  • Fekrat S; Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.
Retina ; 44(1): 159-165, 2024 Jan 01.
Article en En | MEDLINE | ID: mdl-37683266
ABSTRACT
BACKGROUND/

PURPOSE:

To evaluate the status of the posterior vitreous hyaloid on presenting optical coherence tomography images of the macula and its relationship to clinical characteristics, treatment patterns, and outcomes in eyes with central retinal vein occlusion.

METHODS:

This is a retrospective longitudinal cohort study of consecutive patients with acute, treatment-naive central retinal vein occlusion diagnosed between 2009 and 2021 who had at least 12 months of follow-up. Clinical characteristics, treatment patterns, and outcomes were analyzed between eyes stratified based on the presence or absence of a complete posterior vitreous detachment (PVD) on optical coherence tomography at presentation.

RESULTS:

Of 102 acute, treatment-naive central retinal vein occlusions identified, 52 (51%) had complete PVD at presentation and 50 (49%) did not. Central subfield thickness was significantly lower in those with complete PVD (12 months 284.9 ± 122.9 µ m vs. 426.8 ± 286.4 µ m, P < 0.001; last follow-up 278 ± 127.9 vs. 372.8 ± 191.0 µ m, P = 0.022). One-year intravitreal injection burden was significantly less for those with a complete PVD than those without (5.1 ± 3.6 injections vs. 6.7 ± 3.3 injections, P = 0.013).

CONCLUSION:

Central retinal vein occlusion with complete PVD on presentation had significantly lower central subfield thickness and 1-year injection burden. Assessment of the vitreomacular interface in central retinal vein occlusion may serve as a prognostic imaging biomarker.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oclusión de la Vena Retiniana / Desprendimiento del Vítreo Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Retina Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oclusión de la Vena Retiniana / Desprendimiento del Vítreo Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Retina Año: 2024 Tipo del documento: Article